Zimpfer M, Khosropour R, Lackner F
Crit Care Med. 1982 Jun;10(6):367-70. doi: 10.1097/00003246-198206000-00006.
The cardiovascular effects of dobutamine ( 7 micrograms/kg . min iv) and of additional N-allyl-clonidine (St 567, alinidine; 0.3 mg/kg iv), a compound which selectively inhibits the chronotropic effects of various stimulants, were studied in 9 patients scheduled for major abdominal surgery. Dobutamine increased cardiac index (CI), mean arterial pressure (MAP), mean pulmonary artery pressure (MPAP), and heart rate, but failed to change the left ventricular stroke volume (LVSV) significantly. Alinidine decreased cardiac rate and increased LVSV index and left ventricular stroke work index (LVSWI), whereas CI, MAP, and MPAP remained virtually unaffected. Similar results were obtained when the combination of dobutamine and alinidine was given to 4 patients in neuroleptanesthesia. Thus, the decrease in preload which is associated wit tachycardia seems to modify the increase in LVSV in response to inotropic stimulation with dobutamine.
在9例计划接受腹部大手术的患者中,研究了多巴酚丁胺(7微克/千克·分钟静脉注射)以及额外的N-烯丙基可乐定(St 567,阿利尼定;0.3毫克/千克静脉注射)的心血管效应。阿利尼定是一种能选择性抑制各种兴奋剂变时效应的化合物。多巴酚丁胺可增加心脏指数(CI)、平均动脉压(MAP)、平均肺动脉压(MPAP)和心率,但未能显著改变左心室每搏量(LVSV)。阿利尼定可降低心率,并增加LVSV指数和左心室每搏功指数(LVSWI),而CI、MAP和MPAP实际上未受影响。在4例接受神经安定麻醉的患者中给予多巴酚丁胺和阿利尼定联合用药时,也得到了类似结果。因此,与心动过速相关的前负荷降低似乎会改变多巴酚丁胺正性肌力刺激所引起的LVSV增加。